相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis
Meike Heurich et al.
MOLECULAR PSYCHIATRY (2022)
Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress
Melanie Focking et al.
MOLECULAR PSYCHIATRY (2021)
Mass Spectrometry Techniques: Principles and Practices for Quantitative Proteomics
Rocco J. Rotello et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2021)
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence
David Mongan et al.
JAMA PSYCHIATRY (2021)
The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
Melisa Kose et al.
FRONTIERS IN PSYCHIATRY (2021)
Peripheral immune markers and antipsychotic non-response in psychosis
Daniela Enache et al.
SCHIZOPHRENIA RESEARCH (2021)
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis
Thomas A. Pollak et al.
BIOLOGICAL PSYCHIATRY (2021)
Treatment Resistance: A Time-Based Approach for Early Identification in First Episode Psychosis
Kara Dempster et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Resting-state functional connectivity of the striatum predicts improvement in negative symptoms and general functioning in patients with first-episode psychosis: A 1-year naturalistic follow-up study
Sanghoon Oh et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy
Shaoqiang Han et al.
SCHIZOPHRENIA RESEARCH (2020)
The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination
Kathryn A. McGurk et al.
BIOINFORMATICS (2020)
Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosis
Valeria Mondelli et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review
Bruno Pedraz-Petrozzi et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies
David Mongan et al.
SCHIZOPHRENIA RESEARCH (2020)
The Role of Inflammation in the Treatment of Schizophrenia
Guillaume Fond et al.
FRONTIERS IN PSYCHIATRY (2020)
Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders
Thomas A. Pollak et al.
SCHIZOPHRENIA BULLETIN (2019)
How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials
Myrto T. Samara et al.
SCHIZOPHRENIA BULLETIN (2019)
Neuroinflammation and Schizophrenia
Peter F. Buckley
CURRENT PSYCHIATRY REPORTS (2019)
Plasma/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery
Pey Yee Lee et al.
BIOANALYSIS (2019)
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
Emanuela Martinuzzi et al.
TRANSLATIONAL PSYCHIATRY (2019)
Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case-Control Study of the ALSPAC Longitudinal Birth Cohort
Jane A. English et al.
SCHIZOPHRENIA BULLETIN (2018)
Proteomic Analysis of Blood Based Samples From the OPTiMiSE (OPtimization of Treatment and Management of Schizophrenia in Europe) Study Point Towards Complement Pathway Protein Changes
Melanie Focking et al.
BIOLOGICAL PSYCHIATRY (2018)
Responsiveness of the Personal and Social Performance scale in patients with schizophrenia
En-Chi Chiu et al.
PSYCHIATRY RESEARCH (2018)
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Norbert Mueller
SCHIZOPHRENIA BULLETIN (2018)
Interpretation of Serological Complement Biomarkers in Disease
Kristina N. Ekdahl et al.
FRONTIERS IN IMMUNOLOGY (2018)
Is there a role for immune-to-brain communication in schizophrenia?
Golam M. Khandaker et al.
PSYCHOPHARMACOLOGY (2016)
Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment
Deepak K. Sarpal et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Schizophrenia risk from complex variation of complement component 4
Aswin Sekar et al.
NATURE (2016)
Building high-quality assay libraries for targeted analysis of SWATH MS data
Olga T. Schubert et al.
NATURE PROTOCOLS (2015)
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics
Stefan Leucht et al.
SCHIZOPHRENIA BULLETIN (2015)
Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Valeria Mondelli et al.
SCHIZOPHRENIA BULLETIN (2015)
The role of inflammation in schizophrenia
Norbert Mueller et al.
FRONTIERS IN NEUROSCIENCE (2015)
Complement system part II: role in immunity
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Complement system part I - molecular mechanisms of activation and regulation
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Golam M. Khandaker et al.
LANCET PSYCHIATRY (2015)
A polygenic burden of rare disruptive mutations in schizophrenia
Shaun M. Purcell et al.
NATURE (2014)
Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC
M. L. Hamshere et al.
MOLECULAR PSYCHIATRY (2013)
Genome-Wide Association Study Implicates HLA-C*01:02 as a Risk Factor at the Major Histocompatibility Complex Locus in Schizophrenia
Amy Strange et al.
BIOLOGICAL PSYCHIATRY (2012)
Interactions between coagulation and complement-their role in inflammation
Katerina Oikonomopoulou et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms
Bjorn H. Ebdrup et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
Chengjian Tu et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Common variants on chromosome 6p22.1 are associated with schizophrenia
Jianxin Shi et al.
NATURE (2009)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
分享论文
